Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012 (2012), Article ID 293863, 8 pages
http://dx.doi.org/10.1100/2012/293863
Research Article

Prevalence of Isolated Atrial Amyloidosis in Young Patients Affected by Congestive Heart Failure

1Dipartimento di Biotecnologie, Università degli Studi di Siena, Via Fiorentina 1, 53100 Siena, Italy
2Departimento di Patologia Umana e Oncologia, Università degli Studi di Siena, 53100 Siena, Italy

Received 24 October 2011; Accepted 8 December 2011

Academic Editor: Yukio Ando

Copyright © 2012 Lia Millucci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Beauchamp, A. Peeters, A. Tonkin, and G. Turrell, “Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 17, no. 5, pp. 599–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Corradi, R. Maestri, E. MacChi, and S. Callegari, “The atria: from morphology to function,” Journal of Cardiovascular Electrophysiology, vol. 22, no. 2, pp. 223–235, 2011. View at Publisher · View at Google Scholar
  3. A. Biolo, S. Ramamurthy, L. H. Connors et al., “Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition,” Circulation: Heart Failure, vol. 1, no. 4, pp. 249–257, 2008. View at Google Scholar
  4. C. Rapezzi, C. C. Quarta, L. Riva et al., “Transthyretin-related amyloidoses and the heart: a clinical overview,” Nature Reviews Cardiology, vol. 7, no. 7, pp. 398–408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Tsang and R. M. Lang, “Echocardiographic evaluation of cardiac amyloid,” Current Cardiology Reports, vol. 12, no. 3, pp. 272–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. Kistler, P. Sanders, S. P. Fynn et al., “Electrophysiologic and electroanatomic changes in the human atrium associated with age,” Journal of the American College of Cardiology, vol. 44, no. 1, pp. 109–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Sanders, J. B. Morton, N. C. Davidson et al., “Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans,” Circulation, vol. 108, no. 12, pp. 1461–1468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. de Bold, “Atrial natriuretic factor: a hormone produced by the heart,” Science, vol. 230, no. 4727, pp. 767–770, 1985. View at Google Scholar · View at Scopus
  9. F. J. Romero, F. Bosch-Morell, M. J. Romero et al., “Lipid peroxidation products and antioxidants in human disease,” Environmental Health Perspectives, vol. 106, no. 5, pp. 1229–1234, 1998. View at Google Scholar · View at Scopus
  10. K. R. Chien, A. A. Grace, and J. J. Hunter, “Molecular and cellular biology of cardiac hypertrophy and failure,” in Molecular Basis of Cardiovascular Disease, K. R. Chien, Ed., pp. 251–264, WB Saunders, Philadelphia, Pa, USA, 1999. View at Google Scholar
  11. S. M. Rodkey, N. B. Ratliff, and J. B. Young, “Cardiomyopathy and myocardial failure,” in Comprehensive Cardiovascular Medicine, E. J. Topal, Ed., pp. 2589–2620, Lippincott-Raven Publishers, Philadelphia, Pa, USA, 1998. View at Google Scholar
  12. L. M. Shapiro and A. Zezulka, “Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five year experience of a district general hospital,” British Heart Journal, vol. 50, no. 6, pp. 530–533, 1983. View at Google Scholar · View at Scopus
  13. H. Puchtler, F. Sweat, and M. Levine, “On the binding of congo red by amyloid,” Journal of Histochemistry and Cytochemistry, vol. 10, pp. 355–364, 1962. View at Google Scholar
  14. R. P. Linke, “Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence,” Virchows Archiv, vol. 436, no. 5, pp. 439–448, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. G. G. Glenner, “Amyloid deposits and amyloidosis. The β-fibrilloses,” The New England Journal of Medicine, vol. 302, no. 23, pp. 1283–1292, 1980. View at Google Scholar · View at Scopus
  16. J. H. Cooper, “An evaluation of current methods for the diagnostic histochemistry of amyloid,” Journal of Clinical Pathology, vol. 22, no. 4, pp. 410–413, 1969. View at Google Scholar · View at Scopus
  17. J. Seiler and W. G. Stevenson, “Atrial fibrillation in congestive heart failure,” Cardiology in Review, vol. 18, no. 1, pp. 38–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Casaclang-Verzosa, B. J. Gersh, and T. S. M. Tsang, “Structural and functional remodeling of the left atrium. Clinical and therapeutic implications for atrial fibrillation,” Journal of the American College of Cardiology, vol. 51, no. 1, pp. 1–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. K. Heist and J. N. Ruskin, “Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment,” Progress in Cardiovascular Diseases, vol. 48, no. 4, pp. 256–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Röcken, B. Peters, G. Juenemann et al., “Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation,” Circulation, vol. 106, no. 16, pp. 2091–2097, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Nishikimi, K. Kuwahara, and K. Nakao, “Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides,” Journal of Cardiology, vol. 57, no. 2, pp. 131–140, 2011. View at Publisher · View at Google Scholar
  22. L. R. Potter, A. R. Yoder, D. R. Flora, L. K. Antos, and D. M. Dickey, “Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications,” Handbook of Experimental Pharmacology, vol. 191, pp. 341–366, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Ogino, K. Ogura, T. Kinugawa et al., “Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy,” Circulation Journal, vol. 68, no. 5, pp. 444–450, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Ardizzone, F. Cappello, V. di Felice et al., “Atrial natriuretic peptide and CD34 overexpression in human idiopathic dilated cardiomyopathies,” APMIS, vol. 115, no. 11, pp. 1227–1233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Millucci, E. Paccagnini, L. Ghezzi et al., “Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure,” PLoS ONE, vol. 6, no. 7, Article ID e21870, 2011. View at Publisher · View at Google Scholar
  26. E. Arbustini, G. Merlini, A. Gavazzi et al., “Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients,” American Heart Journal, vol. 130, no. 3, pp. 528–536, 1995. View at Google Scholar · View at Scopus
  27. O. B. Suhr, I. H. Svendsen, R. Andersson, A. Danielsson, G. Holmgren, and P. J. Ranløv, “Hereditary transthyretin amyloidosis from a Scandinavian perspective,” Journal of Internal Medicine, vol. 254, no. 3, pp. 225–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Puchtler and F. Sweat, “Congo red as a stain for fluorescence microscopy of amyloid,” Journal of Histochemistry and Cytochemistry, vol. 13, no. 8, pp. 693–694, 1965. View at Google Scholar · View at Scopus
  29. A. S. Cohen, E. Calkins, and C. I. Levene, “Studies on experimental amyloidosis. I. Analysis of histology and staining reactions of casein-induced amyloidosis in the rabbit,” American Journal of Pathology, vol. 35, pp. 971–989, 1959. View at Google Scholar
  30. H. Michels and R. P. Linke, “Clinical benefits of diagnosing incipient AA amyloidosis in pediatric rheumatic diseases as estimated from a retrospective study,” Amyloid, vol. 5, no. 3, pp. 200–207, 1998. View at Google Scholar · View at Scopus